Home Contact
Login   |  Tell a Friend
Financial Optimization through Technology Innovation
mutual fund
 Top Fund Managers
Latest Mutual Fund News Latest Mutual Fund News

Financial Advisor Sponsor:Christine F. Heim, Managing Director


 Bookmark this site!
Follow FundMojo on Twitter
Get Fund Information

Get Stock News

(Enter Stock Symbol)

Partner Sites

Annuities
Wall Street Journal
eHealthInsurance
Fund Mojo on Facebook
Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | FBTIX Insights | FBTIX Score | FBTIX Performance | FBTIX Manager | FBTIX News | FBTIX Allocation | FBTIX Holdings Change

Mutual Fund Insights: Fidelity Advisor Biotechnology I Fund (FBTIX)

In-depth Analysis of Fidelity Advisor Biotechnology I Fund (FBTIX)

Mutual fund chart: Fidelity Advisor Biotechnology I Fund (FBTIX)

3 months
6 months
1 year
3 year
5 year

See Fidelity Advisor Biotechnology I Fund (FBTIX) performance details as of February 28, 2010

  

    Last Trade: $7.85 on 3/19/2010, Change: +0.06 (0.77%)

  

Fund Manager - Rajiv Kaul

Fund Manager Tenure: 4.4 years   [Similar Funds: FBTAX  FBTBX  FBTCX  FBTTX ]
Fundmojo Fund Grade: B (Score: 0.6)     (What does this score mean?)

  

What we like about Fidelity Advisor Biotechnology I Fund (FBTIX) What we like about Fidelity Advisor Biotechnology I Fund (FBTIX)

Data for Fidelity Advisor Biotechnology I Fund (FBTIX) as of February 28, 2010

  • Fidelity Advisor Biotechnology I Fund (FBTIX) management has been with Fidelity Advisor Biotechnology I Fund for 4.4 years
  • Fidelity Advisor Biotechnology I Fund (FBTIX) has good mid-term performance (3-year return 1.78% vs 0.87 % Health category average)
  • Fidelity Advisor Biotechnology I Fund (FBTIX) has good Long-term performance (5-year return 6.39% vs 4.77 % Health category average)
  • Fidelity Advisor Biotechnology I Fund (FBTIX) ratio of up-years vs down years is greater than 2
  • Fidelity Advisor Biotechnology I Fund (FBTIX) has a Morningstar rating of 4 and above
  • Fidelity Advisor Biotechnology I Fund (FBTIX) has an annual stock turnover rate of 73.00% vs Health average of 169.11%. It is good that Fidelity Advisor Biotechnology I management does not trade extensively for its return.
  • Fidelity Advisor Biotechnology I Fund (FBTIX) has a lower management fee than its Health average: 1.11% vs 1.98%
  • Fidelity Advisor Biotechnology I Fund (FBTIX) is a true no-load fund as it has no load and no 12b1 promotion, distributions, marketing expenses

  

What we are cautious about Fidelity Advisor Biotechnology I Fund (FBTIX) What we are cautious about Fidelity Advisor Biotechnology I Fund (FBTIX)

Data for Fidelity Advisor Biotechnology I Fund (FBTIX) as of February 28, 2010

  • Fidelity Advisor Biotechnology I Fund is a focused fund with 61.85% of the portfolio on top 10 securities. This tends to produce more volatility compared to a diversified fund. See fund top 10 holdings.
  • Fidelity Advisor Biotechnology I Fund (FBTIX) has a less-than-ideal short-term performance (1-year return 23.93% vs 40.03 % Health category average)
  • Fidelity Advisor Biotechnology I Fund (FBTIX) is less safe compared to its Health peers
  • Fidelity Advisor Biotechnology I Fund (FBTIX) is more volatile than its peers as it has a 3-year Standard Deviation of 20.94 that is higher than category average of 18.82
See Fidelity Advisor Biotechnology I Fund (FBTIX) performance details as of February 28, 2010

  

  

Interested in other top mutual funds in similar Health category?

Below are some additional Health mutual funds generated out of our database

  

Fidelity Advisor Biotechnology I Fund (FBTIX) Net Asset

Track net asset change of Fidelity Advisor Biotechnology I fund (FBTIX)

DateNet Asset
02/2010$52.69M
01/2010$1.57M
11/2009$1.46M
More historic net asset information on Fidelity Advisor Biotechnology I Fund (FBTIX)

  

Fidelity Advisor Biotechnology I Fund (FBTIX) Portfolio Allocation

Track portfolio allocation change of Fidelity Advisor Biotechnology I fund (FBTIX)

DateCashStockBondOther
01/20100.82%98.95%0%0%
10/20090.01%99.74%0%0.25%
09/20091.82%97.96%0%0.22%
Click here to see more historic asset allocation information on Fidelity Advisor Biotechnology I Fund (FBTIX)

  

Most Recent Top 10 Holdings in Fidelity Advisor Biotechnology I Fund (FBTIX)

Discover what Fidelity Advisor Biotechnology I Fund (FBTIX) manager is buying

31-Jan-10
Amgen Inc. [20.16%]
Gilead Sciences, Inc. [6.74%]
Alexion Pharmaceuticals, Inc. [5.93%]
Vertex Pharmaceuticals Incorpor [4.34%]
Acorda Therapeutics, Inc. [4.31%]
United Therapeutics Corporation [4.23%]
Biogen Idec Inc [4.22%]
Genzyme Corporation [4.16%]
Cephalon, Inc. [4.02%]
BioMarin Pharmaceutical Inc. [3.74%]

31-Oct-09
Amgen Inc. [21.24%]
Biogen Idec Inc [8.68%]
Alexion Pharmaceuticals, Inc. [6.38%]
Vertex Pharmaceuticals Incorpor [5.01%]
United Therapeutics Corporation [4.89%]
Gilead Sciences, Inc. [4.57%]
Genzyme Corporation [4.57%]
Cephalon, Inc. [3.71%]
Acorda Therapeutics, Inc. [3.66%]
Celgene Corporation [3.61%]

30-Sep-09
Amgen Inc. [20.07%]
Biogen Idec Inc [8.91%]
Alexion Pharmaceuticals, Inc. [5.48%]
United Therapeutics Corporation [4.96%]
Vertex Pharmaceuticals Incorpor [4.84%]
Genzyme Corporation [4.69%]
Gilead Sciences, Inc. [4.26%]
Celgene Corporation [3.62%]
Dendreon Corporation [3.41%]
Cephalon, Inc. [3.38%]
Click here for Stock Holding Change Map in Fidelity Advisor Biotechnology I Fund (FBTIX)

  

Related books and products to Fidelity Advisor Biotechnology I Fund (FBTIX)

  

Latest News on Fidelity Advisor Biotechnology I (FBTIX)

See what is happening with Fidelity Advisor Biotechnology I Fund (FBTIX)

 

Books and Resources

 

 

See more information on Fidelity Advisor Biotechnology I Fund (FBTIX)